Prolyl 3-hydroxylation of type IV collagen is obligatory to avoid early 
embryoniclethality in mice

Pokidysheva, Elena; Boudko, Sergei; Vranka, Janice; Keene, Douglas; Tufa, Sara; Zentek, Keith; Moser, Markus; Fässler, Reinhard; Ware, Jerry; Baechinger, Hans Peter

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

会議抄録

Prolyl 3-hydroxylation of type IV collagen is obligatory to avoid early embryoniclethality in mice

MPS-Authors

/persons/resource/persons78420

Moser, Markus
Fässler, Reinhard / Molecular Medicine, Max Planck Institute of Biochemistry, Max Planck Society;

/persons/resource/persons77945

Fässler, Reinhard
Fässler, Reinhard / Molecular Medicine, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Pokidysheva, E., Boudko, S., Vranka, J., Keene, D., Tufa, S., Zentek, K., Moser, M., Fässler, R., Ware, J., & Baechinger, H. P. (2012). Prolyl 3-hydroxylation of type IV collagen is obligatory to avoid early embryoniclethality in mice. GLYCOBIOLOGY, 22(11), 1524-1524.

引用: https://hdl.handle.net/11858/00-001M-0000-000E-7A2F-F

要旨

要旨はありません